1-8 of 8
Jianying Huang
Close
Sort by
Journal Articles

Alrizomadlin (APG-115) Alone or Combined with Azacitidine (AZA) in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Relapsed or Progressive Higher-Risk Myelodysplastic Syndrome (HR-MDS): Phase 1b Trial Results

Junyuan Qi, Xudong Wei, Qiubai Li, Chukang Chang, Fuling Zhou, Jianying Huang, Yu Zhang, Chongyuan Xu, Xiaowen Tang, Qian Jiang, Junmin Li, Qun Qin, Qun He, Sujun Gao, Liping Liu, Zi Chen, Min Yu, Jing Wang, Lichuang Men, Hengbang Wang, Mohammad Ahmad, Dajun Yang, Yifan Zhai, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5954.
https://doi.org/10.1182/blood-2023-184959
Published: 2023
Journal Articles

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Keshu Zhou, Mingyuan Sun, Xu Wei, Shuhua Yi, Junyuan Qi, Weiqi Nian, Guohui Cui, Jishi Wang, Xiaoping Zhang, Hong Cen, Fuling Zhou, Jianying Huang, Huilan Liu, Aizong Shen, Liangquan Geng, Ru Feng, Chongyuan Xu, Wenbin Qian, Fei Li, Lihong Liu, Caixia Li, Xielan Zhao, Jie Jin, Hongmei Jing, Dongmei Ji, Fangfang Lyu, Zi Chen, Lichuang Men, Hengbang Wang, Ke Zhang, Liang Xu, Zhang Zhang, Dajun Yang, Jianxiang Wang, Jianyong Li, Yifan Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 1900.
https://doi.org/10.1182/blood-2023-183071
Published: 2023
Journal Articles

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Patients (pts) with Certain Relapsed or Refractory (R/R) Hematologic Malignancies (HMs)

Mingyuan Sun, Junyuan Qi, Zi Chen, Hongli Zhang, Yongping Song, Aizong Shen, Huilan Liu, Jianying Huang, Fuling Zhou, Jie Jin, Ming Lu, Mohammad Ahmad, Lichuang Men, Wan Cen, Dajun Yang, Jianxiang Wang, Yifan Zhai
Journal: Blood
Blood (2021) 138 (Supplement 1): 3730.
https://doi.org/10.1182/blood-2021-152235
Published: 2021
Journal Articles

Preliminary Results from a Phase I Study of SHC014748M in Patients with Relapsed or Refractory Indolent B-Cell Lymphomas

Wei Xu, MD PhD, Jie Jin, MD PhD, Keshu Zhou, MD, Li Wang, MD, Huayuan Zhu, Jiejing Qian, Jianying Huang, Fuling Zhou, MD, Xiaohong Xu, Zhiqiang Wang, Wei Guo, Jianyong Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4000.
https://doi.org/10.1182/blood-2019-126707
Published: 2019
Journal Articles

Baicalein Synergy Lenalidomide To Induce Apoptosis Of Myeloma Cell

Ruibo Zhang, Jr., Zi Ma, Sr., Shangqin Liu, Sr., PHD, Li He, Jr., Chaoping Xu, Jr., Guiying Hu, Jianying Huang, Yicheng Zhang
Journal: Blood
Blood (2013) 122 (21): 5328.
https://doi.org/10.1182/blood.V122.21.5328.5328
Published: 2013
Journal Articles

Expression Of Cancer-Testis Antigen In Multiple Myeloma

Jingna Ji, Jr, Shangqin Liu, Sr., PHD, Li He, Chaoping Xu, Jr., Guiying Hu, Yicheng Zhang, Zi Ma, Sr., Jianying Huang
Journal: Blood
Blood (2013) 122 (21): 5341.
https://doi.org/10.1182/blood.V122.21.5341.5341
Published: 2013
Journal Articles

Baicalein Inhibites Multiple Myeloma Cells Proliferation and Migration by Interfering Wnt Signaling Pathway

Chaoping Xu, Jr., Shangqin Liu, Sr., Jianying Huang, Sr., Yicheng Zhang, Sr., Li He, Jr., Huili Cai, Jr., Ruibo Zhang, Jr., Jinna Ji, Jr., Dingxin Zhou, Jr., Zi Ma, Sr.
Journal: Blood
Blood (2012) 120 (21): 5019.
https://doi.org/10.1182/blood.V120.21.5019.5019
Published: 2012
Journal Articles

Induction of CRBN(Cereblon) mRNA Expression by Baicalein

Zi Ma, Sr., Rui bo Zhang, Li He, Chao ping Xu, Ding xin Zhou, Jing na Ji, Jianying Huang, Yicheng Zhang, Sr., Shang qin Liu, Sr.
Journal: Blood
Blood (2012) 120 (21): 5025.
https://doi.org/10.1182/blood.V120.21.5025.5025
Published: 2012